Showing results (501-510 of 745) with videos related to
Sort By:
Pageof 75
Human Vaccines & Immunotherapeutics|June 23, 2023
Pediatric hematology and oncology physician and nurse practitioner views of the HPV vaccine and barriers to administrationMeagan E Miller, Mahvish Q Rahim, Scott L Coven, et al.Immunology|November 1, 1991
Expression of Epstein-Barr virus nuclear antigens in anti-IgM-stimulated B cells following recombinant vaccinia infection and their recognition by human cytotoxic T cellsR Khanna, C A Jacob, S R Burrows, et al.Frontiers in Immunology|May 1, 2024
The interleukin-4/interleukin-13 pathway in type 2 inflammation in chronic rhinosinusitis with nasal polypsClaus Bachert, Alexandra Hicks, Simon Gane, et al.Biophysical Journal|May 5, 2011
Torsion stiffness of a protein pair determined by magnetic particlesX J A Janssen, J M van Noorloos, A Jacob, et al.Innovations (Philadelphia, Pa.)|September 13, 2024
Cost Analysis of Robot-Assisted Versus On-Pump and Off-Pump Coronary Artery Bypass Grafting: A Single-Center Surgical and 30-Day Outcomes ComparisonMonica Gianoli, Anne R de Jong, Pim van der Harst, et al.Revista Brasileira De Reumatologia|June 9, 2016
Chronic polyarthritis as isolated manifestation of toxocariasisGabriela R Viola, Maria Fernanda A Giacomin, Camila M P França, et al.Expert Review of Gastroenterology & Hepatology|February 5, 2025
Dupilumab is efficacious for eosinophilic esophagitis irrespective of prior swallowed budesonide or fluticasone, or prior treatments used alongside swallowed topical corticosteroids: results from the phase 3, randomized, placebo-controlled, LIBERTY EoE TREET trialAlbert J Bredenoord, Evan S Dellon, Christoph Schlag, et al.The Journal of Experimental Medicine|July 1, 1992
Localization of Epstein-Barr virus cytotoxic T cell epitopes using recombinant vaccinia: implications for vaccine developmentR Khanna, S R Burrows, M G Kurilla, et al.Therapeutic Advances in Neurological Disorders|March 6, 2023
Microglia as a cellular target of diclofenac therapy in Alzheimer's diseaseBarbara E Stopschinski, Rick A Weideman, Danni McMahan, et al.Journal of Gastroenterology and Hepatology|April 21, 2007
Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cellsDietmar A Jacob, Marcus Bahra, Jan M Langrehr, et al.Pageof 75